-
RDIF, Panacea Biotec launch production of Sputnik V in India
expresspharma
May 25, 2021
The Russian Direct Investment Fund (RDIF) and Panacea Biotec announced the launch of production of the Russian Sputnik V vaccine against coronavirus.
-
Bal Pharma launches BALflu (favipiravir) tablets in India
expresspharma
May 25, 2021
Bal Pharma announced the launch of Favipiravir formulation in the Indian market, under the brand name BALflu.
-
BioNTech says vaccine likely to be effective against Indian variant
expresspharma
May 24, 2021
BioNTech SE said yesterday that the COVID-19 vaccine it developed with Pfizer should be roughly as effective against the new coronavirus variant first detected in India as it has been shown to be against the South African variant.
-
India, Pfizer discuss vaccine deal, seek to resolve dissension over vaccine indemnity: Report
expresspharma
May 24, 2021
India has not given any manufacturer of a COVID-19 vaccine indemnity against the costs of compensation for any severe side effects, which is a condition Pfizer has obtained in many countries.
-
American civil rights leader to request US President to release 60 million COVID-19 vaccine doses to India
expresspharma
May 20, 2021
Rev. Jackson will be joined by a number of prominent Indian leaders in Washington to make a public appeal to Biden for more humanitarian aid, according to a community statement.
-
Boehringer Ingelheim allocates one million Euros to fight COVID-19 in India
expresspharma
May 19, 2021
Boehringer Ingelheim informed that it is making available one million Euros for COVID relief fund to enable sustenance and livelihoods of underserved and tribal communities, and address medical needs of patients in India, through the 2021-22 financial ...
-
Pregene and Dr. Reddy's Announce License Agreement for Anti-BCMA CAR-T PRG1801 in India
prnasia
May 13, 2021
Dr. Reddy's Laboratories Ltd. and Shenzhen Pregene Biopharma Co., Ltd. today announced an agreement whereby Dr Reddy's will acquire an exclusive license in the Republic of India for PRG1801, Pregene's single domain antibody-based anti-BCMA chimeric ...
-
Parliamentary panel had recommended ramping up vaccine manufacturing capacity in March
expresspharma
May 13, 2021
The recommendations made by the 31-member committee that reportedly had as many as 14 members from the ruling BJP was tabled in Parliament on March 8.
-
India, US confer on collaboration in pharma sector
expresspharma
May 12, 2021
The US has already sent a large amount of medical supplies to help India deal with a severe second wave of the pandemic.
-
Vivimed gets DGHI nod to manufacture, market favipiravir tablet in India
expresspharma
May 11, 2021
Vivimed Labs announced the receipt of Government of India (Director General of Health Services) approval to manufacture and market Favipiravir Tablet 200 mg and 400 mg under Vivimed’s own brand name ‘Favulous’ across India.